Back
Edge
StocktwitsEarnings
Official STOCKTWITS Representative
symbol logo$IOVA Q2 '26 Earnings Results & Recap • Reported GAAP EPS of -$0.11 up 66.67% YoY • Reported revenue of $198.63M up 231.31% YoY • Iovance Biotherapeutics is reviewing its previously issued 2026 total revenue guidance of $350 million to $370 million based on strong second-quarter sales and current demand trends, with an update expected later.
1
2
43

Price since post

Full Details
VicAge
you guys really got to proof read your posts, are you guys pumping a stock?

Advertisement|Remove ads.